Status : Published Published On : Sep, 2021 Report Code : VRHC1211 Industry : Healthcare Available Format : Page : 127

Global Biobanking Market - Analysis and Forecast (2021-2027)
Industry insights by Storage Type (Manual and Automated), by Offering (Consumables, Equipment, Services, and Software), by Applications (Clinical Research, Life Science and Medical Research, and Regenerative Medicine), by Utility Needs (Research, Routine, and Epidemiology ), by Geography (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Japan, China, India, Australia, South Korea, Brazil, U.A.E, Saudi Arabia, South Africa)

Industry Overview

The global biobanking market was valued at USD 24,356 million in 2020 and is expected to grow at a CAGR of 6.8% during the forecast period (2021-2027). Several offerings such as consumables and equipment, majorly contribute to the biobanking market size. Increasing the prevalence of chronic diseases, increasing demand for value-based care, increasing investment for genomic research, increasing awareness, robust pipeline for cell therapy are leading to the growth of the market.

Biobanking Market Highlights

Market Segmentation

Insight by Storage Type

Based on storage type biobanking market is categorized into manual and automated, on the basis of the product. Among the two categories, the demand for automated biobanking storage is growing at a higher rate. The trend is anticipated to continue in the coming years due to the increasing need for automation, advancements in technology, need for storage of contamination-free samples.

Insight by Offering

Based on offerings, the biobanking market is segmented into consumables, equipment, services, and software. Consumables hold the largest share in the biobanking market, globally primarily due to the frequent purchases over the years. The market for biobanking services is anticipated to grow significantly during the forecast period as new players are emerging to provide biobanking services with novel approaches.

Insight by Application

Based on application the market is categorized into life science and medical research, clinical research, and regenerative medicine. Of all the categories, biobanking is mostly used for clinical research purposes as the need for value-based treatments for various therapeutic areas is on the rise significantly across the globe. Also, with the advancements in cell therapy, the market for regenerative medicines is also growing at a significant rate.

Insight by Utility Needs

Based on utility needs, the market is categorized into routine, research, and epidemiology. The biobanking market is anticipated to hold a significant share for research due to the increasing research funding by the large biopharmaceutical companies across the globe.

Global Biobanking Market Report Coverage

Report Metric


Historical Period


Base Year Considered


Forecast Period

2021 - 2027

Market Size in 2020

$24,356 Million

Revenue Forecast in 2030

$xx.x Million

Growth Rate

CAGR 6.8%

Segments Covered in the Report

By Storage Type, By Offering, By Application, By Utility Needs

Report Scope

Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling

Regions Covered in the Report

North America, Europe, Asia-Pacific, Middle East, and Rest of the World

Industry Dynamics

Growth Drivers

The growing awareness on the therapeutic potential of stem cells, increasing approval of clinical trials in using cord blood cells, advances in biobanking; increasing government funding for regenerative medicines; and development of novel technologies for stem cell preservation, storage, and processing, are the primary growth drivers for stem cell banking industry. Initiatives are taken by various companies and organizations to broaden awareness biobanking. For instance, in the U.S. was formed to increase the awareness about the umbilical cord blood stem cells.

Growing global burden of chronic disease, increasing healthcare expenditure and public awareness related to the therapeutic potential of stem cells are also fueling the growth of the biobanking market.


The strict regulatory framework and high operational and processing costs are the major challenges for the growth of the biobanking market. Moreover, the socio-ethical issues associated with biobanking and the high cost of automation are impeding the growth of the global market.

Geography Insight

Geographically, North America is the largest market for biobanking. Some of the key factors leading to the growth of the North American market are technological advancement in the field of preservation and collection technique, availability of federal funding for research, and ongoing approvals for regenerative medicines. Asia-Pacific is the fastest-growing biobanking industry primarily due to the high potential of China. The growth in the region is centered in China, Japan and India as these countries have been developing their Lifesciences industry infrastructure with the increasing research funding.

Competitive Insight

Some of the key players operating in the global biobanking market are BioLifeSolutions Inc, Becton, Dickinson and Company, Atlanta Biologicals Inc., Merck KGaA, Thermo Fisher Scientific Inc., STEMCELL Technologies Inc., Qiagen NV, Chart Industries Inc., VWR International LLC, Hamilton Company, PHC Holdings Corporation, Avantor Inc, and AlphaCord LLC.

Forecast Parameters

- Identifying variables and establishing market impact.

- Establishing market trends regionally.

- Analyzing opportunities and market penetration rates by understanding product commercialization, regional expansion.

- Analyzing demand and supply trends and changes in industry dynamics to establish future growth.

- Analyzing sustainability strategies adhered by market participants in an attempt to determine future course of the market.

- Analyzing historical market trends and super-imposing them on the current and future variables to determine the year-on-year trends.

- Understanding adoption, production, export, import, and regulatory framework.

Data Validation

- Estimated and forecasted data was validated through industry experts.

- Apart from industry experts, data triangulation methods were used for validation.

- Bottom-up and top-down approach has been used for estimation and forecast of market data, whereas the top-down approach was used for validation.

- Demand, as well as supply-side surveys, were conducted in order to understand the industry dynamics and data validation.

Primary Research

VynZ Research conducts extensive primary research to understand the market dynamics, validate market data and have key opinions from the industry experts. The key profiles approached within the industry include CEO, CFO, CTO, President, Vice President, Product Managers, Regional Heads, and Others. Also, end-user surveys comprising of consumers are also conducted to understand consumer behavior.

The Biobanking Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2021–2027.

Segments Covered in the Report

  • By Type 
    • Manual
    • Automated
  • By Offering 
    • Consumables
    • Equipment
    • Services
    • Software
  • By Application 
    • Clinical Research
    • Life Science and Medical Research
    • Regenerative Medicine
  • By Utility Needs 
    • Research
    • Routine
    • Epidemiology

Region Covered in the Report

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World (RoW)
    • Brazil
    • Saudi Arabia
    • South Africa
    • U.A.E.
    • Other Countries

Biobanking Market Analysis

Source: VynZ Research

Frequently Asked Questions

The global biobanking market was valued at USD 24,356 million in 2020.
Based on offering, consumables hold the largest share in the biobanking market.
The strict regulatory framework and high operational and processing costs are the major challenges for the growth of the biobanking market.
Asia-Pacific region offers greater investment opportunities in the near future.
The global biobanking market is expected to grow at a CAGR of 6.8% during the forecast period 2021-2027.

Place an order

Research Methodology

  •  Desk Research / Pilot Interviews
  •  Build Market Size Model
  •  Research and Analysis
  •  Final Deliverabvle